Dasatinib Tablet, Film Coated
NDC Package 62332-686-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Dasatinib tablets is a medication used to treat certain types of cancer (chronic myeloid leukemia-CML, acute lymphoblastic leukemia-ALL). This formulation utilizes a tablet, film coated delivery system. Marketed by Alembic Pharmaceuticals Inc., this product is identified by NDC 62332-686 and is authorized under FDA application ANDA216261.

Identification & Billing

NDC Package Code
62332-686-60
Package Description
60 TABLET, FILM COATED in 1 BOTTLE
Product Code
62332-686
11-Digit Billing Format
62332068660
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Dasatinib
Non-Proprietary Name
Dasatinib
Substance Name
Dasatinib
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
DASATINIB 70 mg/1
Pharmacologic Class
Usage Information
This medication is used to treat certain types of cancer (chronic myeloid leukemia-CML, acute lymphoblastic leukemia-ALL). It works by slowing or stopping the growth of cancer cells.

Regulatory & Marketing

Labeler Name
Alembic Pharmaceuticals Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA216261
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-11-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62332-686-60 identifies a specific commercial package of 60 tablet, film coated in 1 bottle of Dasatinib, a human prescription drug labeled by Alembic Pharmaceuticals Inc.. This tablet, film coated is formulated for oral use and contains dasatinib as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alembic Pharmaceuticals Inc. on November 11, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat certain types of cancer (chronic myeloid leukemia-CML, acute lymphoblastic leukemia-ALL). It works by slowing or stopping the growth of cancer cells.

How is this Alembic Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62332068660. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62332-686-60
11-Digit CMS (5-4-2)
62332-0686-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.